Sunshine Biopharma Inc. Proceeds from Issuance or Sale of Equity
Sunshine Biopharma Inc. (SBFM) reported Proceeds from Issuance or Sale of Equity of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2018-11-16
- Sunshine Biopharma Inc. proceeds from issuance or sale of equity for the quarter ending 2018-09-30 was $0.00.
- Sunshine Biopharma Inc. proceeds from issuance or sale of equity for the quarter ending 2017-09-30 was $0.00.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $0.00 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-17 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $63.91K 10-Q · filed 2018-11-16 | |
| 2017-06-30 | $63.91K 10-Q · filed 2018-08-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |